• Study Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France Germany Greece Italy The Netherlands Spain
  • Study on Mitomycin, Capecitabine, Ipilimumab, and Nivolumab for Muscle Invasive Bladder Cancer Treatment in Patients Seeking Bladder-Sparing Options

    Not recruiting

    1 1 1 1
    Investigated diseases:
    The Netherlands
  • Study of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma

    Not recruiting

    1 1 1 1
    France
  • Study of Sacituzumab Govitecan for Patients with Muscle-Invasive Bladder Cancer Unable or Unwilling to Use Cisplatin-Based Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on Cladribine for Treating Seropositive Myasthenia Gravis in Patients

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on the Effects of AZD5004 for Adults with Obesity or Overweight and a Related Medical Condition

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on the Effects of Vibozilimod for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Estonia Poland
  • Study of MCLA-129 with Chemotherapy and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium France Germany Italy The Netherlands Spain
  • Study of Dasatinib and Quercetin combination for treating liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

    Not recruiting

    2 1 1
    The Netherlands
  • Study on Norucholic Acid for Treating Primary Sclerosing Cholangitis in Patients

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Denmark Finland France Germany Hungary +3

powered by